Patents by Inventor Assaad A. Eid

Assaad A. Eid has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12127854
    Abstract: Provided herein are systems, methods and apparatuses an antenna array or a group of antenna elements for biomarker monitoring, nerve stimulations, and methods of use.
    Type: Grant
    Filed: July 28, 2021
    Date of Patent: October 29, 2024
    Assignee: American University of Beirut
    Inventors: Joseph Costantine, Rouwaida Kanj, Youssef Tawk, Assaad Eid, Jessica Hanna, Ali H. Ramadan
  • Publication number: 20240350046
    Abstract: Provided herein are compact sensor continuously and wirelessly senses blood constituents including a mm-wave newly designed sensor validates its ability to correlate received base-band power levels variations, rather than S-parameters, with the variations in blood glucose levels of serum [FBS] and in that of the jugular veins and carotid arteries for animals and humans.
    Type: Application
    Filed: April 17, 2024
    Publication date: October 24, 2024
    Inventors: Hoda Farhat, Joseph Costantine, Rouwaida Kanj, Youssef Tawk, Assaad Eid, Ali H. Ramadan
  • Patent number: 11923880
    Abstract: An electromagnetic (EM)-based diagnostics and monitoring system and method for the non-Invasive diagnosis and monitoring of in-vivo and ex-vivo Skin Anomalies Using Lesion-Optimized Sensor System Design and Topology is disclosed herein.
    Type: Grant
    Filed: May 25, 2022
    Date of Patent: March 5, 2024
    Assignee: American University of Beirut
    Inventors: Nader Shafi, Joseph Costantine, Rouwaida Kanj, Youssef Tawk, Assaad Eid, Mazen Kurban, Jihane Abou Rahal, Ali H. Ramadan
  • Publication number: 20220385315
    Abstract: An electromagnetic (EM)-based diagnostics and monitoring system and method for the non-Invasive diagnosis and monitoring of in-vivo and ex-vivo Skin Anomalies Using Lesion-Optimized Sensor System Design and Topology is disclosed herein.
    Type: Application
    Filed: May 25, 2022
    Publication date: December 1, 2022
    Inventors: Nader Shafi, Joseph Costantine, Rouwaida Kanj, Youssef Tawk, Assaad Eid, Mazen Kurban, Jihane Abou Rahhal, Ali H. Ramadan
  • Publication number: 20220054087
    Abstract: Provided herein are systems, methods and apparatuses an antenna array or a group of antenna elements for biomarker monitoring, nerve stimulations, and methods of use.
    Type: Application
    Filed: July 28, 2021
    Publication date: February 24, 2022
    Inventors: Joseph Costantine, Rouwaida Kanj, Youssef Tawk, Assaad Eid, Jessica Hanna, Ali H. Ramadan
  • Publication number: 20220039682
    Abstract: Provided herein are systems, methods and apparatuses for a Biomarker sensor.
    Type: Application
    Filed: August 23, 2021
    Publication date: February 10, 2022
    Inventors: Moussa Bteich, Joseph Costantine, Rouwaida Kanj, Assaad Eid, Youssef Tawk, Ali H. Ramadan
  • Patent number: 11197612
    Abstract: The device measures glucose concentration in blood without any extraction of blood. The device is a non-invasive method for measuring glucose Radio Frequency and Antenna Circuits and Systems. The device is a wearable device that can non-invasively measure blood glucose levels in an instantaneous manner and continuous manner.
    Type: Grant
    Filed: October 5, 2018
    Date of Patent: December 14, 2021
    Assignee: American University of Beirut
    Inventors: Joseph Costantine, Rouwaida Kanj, Assaad Eid
  • Patent number: 11134860
    Abstract: Provided herein are systems, methods and apparatuses for an Antenna Design for Biomarker Monitoring.
    Type: Grant
    Filed: June 26, 2019
    Date of Patent: October 5, 2021
    Assignee: American University of Beirut
    Inventors: Joseph Costantine, Rouwaida Kanj, Assaad Eid, Jessica Hanna, Ali H. Ramadan, Youssef Tawk
  • Publication number: 20210087634
    Abstract: A method for a determining of risk for development of cardiovascular disease by measuring levels of the at least gene of interest is disclosed. The method may identify subjects with moderate albuminuria and diagnosis or predict cardiovascular disease several years before either of these outcomes is detectable by present methodologies.
    Type: Application
    Filed: October 13, 2020
    Publication date: March 25, 2021
    Inventors: Kamal F. Badr, Assaad A. Eid, Robert H. Habib
  • Patent number: 10801066
    Abstract: A method for a determining of risk for development of cardiovascular disease by measuring levels of the at least gene of interest is disclosed. The method may identify subjects with moderate albuminuria and diagnosis or predict cardiovascular disease several years before either of these outcomes is detectable by present methodologies.
    Type: Grant
    Filed: September 8, 2015
    Date of Patent: October 13, 2020
    Assignee: American University of Beirut
    Inventors: Kamal F. Badr, Assaad A Eid, Robert H. Habib
  • Publication number: 20190388000
    Abstract: Provided herein are systems, methods and apparatuses for an Antenna Design for Biomarker Monitoring.
    Type: Application
    Filed: June 26, 2019
    Publication date: December 26, 2019
    Inventors: Joseph Costantine, Rouwaida Kanj, Assaad Eid, Jessica Hanna, Ali H. Ramadan, Youssef Tawk
  • Publication number: 20190104939
    Abstract: The device measures glucose concentration in blood without any extraction of blood. The device is a non-invasive method for measuring glucose Radio Frequency and Antenna Circuits and Systems. The device is a wearable device that can non-invasively measure blood glucose levels in an instantaneous manner and continuous manner.
    Type: Application
    Filed: October 5, 2018
    Publication date: April 11, 2019
    Inventors: Joseph Costantine, Rouwaida Kanj, Assaad Eid
  • Publication number: 20160068911
    Abstract: A method for a determining of risk for development of cardiovascular disease by measuring levels of the at least gene of interest is disclosed. The method may identify subjects with moderate albuminuria and diagnosis or predict cardiovascular disease several years before either of these outcomes is detectable by present methodologies.
    Type: Application
    Filed: September 8, 2015
    Publication date: March 10, 2016
    Inventors: Kamal F. BADR, Assaad A. Eid, Robert H. Habib